Advanced search
Publication Cover
Drug Delivery Volume 25, 2018 - Issue 1
Submit an article Journal homepage
1,602
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Low-density lipoprotein decorated silica nanoparticles co-delivering sorafenib and doxorubicin for effective treatment of hepatocellular carcinoma

Junfeng YeDepartment of Hepato-Biliary-Pancreatic Surgery, First Hospital of Jilin University, Changchun, PR ChinaView further author information
,
Ruoyan ZhangDepartment of Hepato-Biliary-Pancreatic Surgery, First Hospital of Jilin University, Changchun, PR ChinaView further author information
,
Wengang ChaiDepartment of Hepato-Biliary-Pancreatic Surgery, First Hospital of Jilin University, Changchun, PR ChinaView further author information
&
Xiaohong DuDepartment of Hepato-Biliary-Pancreatic Surgery, First Hospital of Jilin University, Changchun, PR ChinaCorrespondence[email protected]
View further author information
Pages 2007-2014 | Received 20 Aug 2018, Accepted 01 Oct 2018, Published online: 27 Dec 2018

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Zhuo-Yue Li, Yi-Fan Yin, Yang Guo, Hui Li, Mei-Qi Xu, Man Liu, Jing-Ru Wang, Zhen-Han Feng, Xiao-Chuan Duan, Shuang Zhang, Shuai-Qiang Zhang, Guang-Xue Wang, Ai Liao, Shu-Min Wang & Xuan Zhang. (2020) Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid. International Journal of Nanomedicine 15, pages 1809-1821.
Read now
Jie Zhao, Bin Wen, Zhengbing Tan, Xinyan Li & Xuesong Zhang. (2020) iRGD-targeted hybrid nanoparticles reverses multi-drug resistant to effectively combat liver cancer. Journal of Drug Targeting 28:10, pages 1063-1070.
Read now
Hongying Pan, Yi Sun, Danxia Cao & Lihui Wang. (2020) Low-density lipoprotein decorated and indocyanine green loaded silica nanoparticles for tumor-targeted photothermal therapy of breast cancer. Pharmaceutical Development and Technology 25:3, pages 308-315.
Read now

Articles from other publishers (14)

Yi Feng, Zhen Liao, Hanxi Zhang, Xiaoxue Xie, Fengming You, Xiaoling Liao, Chunhui Wu, Wei Zhang, Hong Yang & Yiyao Liu. (2023) Emerging nanomedicines strategies focused on tumor microenvironment against cancer recurrence and metastasis. Chemical Engineering Journal 452, pages 139506.
Crossref
Binghong He & Qiong Yang. (2022) Recent Development of LDL-Based Nanoparticles for Cancer Therapy. Pharmaceuticals 16:1, pages 18.
Crossref
Jia Gu, Neng Zhu, Hong-Fang Li, Tan-Jun Zhao, Chan-Juan Zhang, Duan-Fang Liao & Li Qin. (2022) Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor. Cellular Oncology 45:5, pages 709-728.
Crossref
Shanshan Wang, Qianzhou Lv & Xiaoyu Li. (2022) Recent Advances in Drug Delivery Nanocarriers for Targeting Hepatocellular Carcinoma. Journal of Nanomaterials 2022, pages 1-8.
Crossref
An Wang & Jian-Shuai Jiang. (2022) Research on Mechanism of Doxorubicin Carried with Mesoporous Silica Nanoparticles Mesoporous Silica Nanoparticles in Regulating the Activity of Liver Tumor Cells Through Regulating the Activity of Hippo-Yes-Associated Protein Signal Pathway. Science of Advanced Materials 14:3, pages 521-527.
Crossref
Xiu-Ping Zhang, Xiang-Jun Chen, Bo-Zhao Li, Shuai Xu, Zhou-Liang Wu, Ming-Gen Hu, Zhi-Ming Zhao, Guo-Dong Zhao, Chang-Rong Wang, Wei Hong, Su-Ping Li, Lu Li, Chun-Gang Wang, Guangjun Nie & Rong Liu. (2022) Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence. Biomaterials 281, pages 121362.
Crossref
Mohamed Fawzi Kabil, Maha Nasr & Ibrahim M. El-Sherbiny. (2021) Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 9-37.
Crossref
Yunxi Liu, Yue Chen, Weidong Fei, Caihong Zheng, Yongquan Zheng, Miao Tang, Ying Qian, Xiao Zhang, Mengdan Zhao, Meng Zhang & Fengmei Wang. (2021) Silica-Based Nanoframeworks Involved Hepatocellular Carcinoma Theranostic. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Mohammed Mehadi Hassan Chowdhury, Christiancel Joseph J. Salazar & Md Nurunnabi. (2021) Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomaterials Science 9:14, pages 4821-4842.
Crossref
Huili Lai, Liping Zhong, Yong Huang, Yongxiang Zhao & Zhiyong Qian. (2021) Progress in Application of Nanotechnology in Sorafenib. Journal of Biomedical Nanotechnology 17:4, pages 529-557.
Crossref
Haroon Iqbal, Tao Yang, Ting Li, Miya Zhang, Hengte Ke, Dawei Ding, Yibin Deng & Huabing Chen. (2021) Serum protein-based nanoparticles for cancer diagnosis and treatment. Journal of Controlled Release 329, pages 997-1022.
Crossref
Xiangjun Chen, Xiuping Zhang, Lingyu Zhang, Guodong Zhao, Shuai Xu, Lu Li, Zhongmin Su, Rong Liu & Chungang Wang. (2021) An EPR-independent therapeutic strategy: Cancer cell-mediated dual-drug delivery depot for diagnostics and prevention of hepatocellular carcinoma metastasis. Biomaterials 268, pages 120541.
Crossref
Lijun Wang, Cunzhi Lin, Nina Sun, Qiang Wang, Xiaoqian Ding & Yong Sun. (2020) Long non‐coding RNA CASC19 facilitates non‐small cell lung cancer cell proliferation and metastasis by targeting the miR‐301b‐3p/LDLR axis. The Journal of Gene Medicine 22:12.
Crossref
Hasnat Tariq & Syed Ali Imran Bokhari. (2020) Surface‐functionalised hybrid nanoparticles for targeted treatment of cancer. IET Nanobiotechnology 14:7, pages 537-547.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.